BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 8, 2002
View Archived Issues
Cephalon Partners Cancer Program With Novuspharma
In a three-year collaboration entered Tuesday with Cephalon Inc., Novuspharma SpA will use its preclinical research technology to screen a number of cancer compounds provided by Cephalon. (BioWorld Today)
Read More
Arriva Arrives, Closes $28M Series D Round For Trials
Read More
Irradiating Mice Makes Their Cells Cancerous; Non-Irradiated Pups, Grand-Pups, Get Same Syndrome
Read More
Vasogen Raises $10.8M For Immune Modulation Therapy
Read More
Other News To Note
Read More
NeoTherapeutics Looking To License Out Drug Candidates
Read More